Ana Rio-Machin - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Ana Rio-Machin

Showing results (11-20 of 20) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 20 results.

Signal Transduction and Targeted Therapy|February 27, 2023

Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypesPedro Casado, Ana Rio-Machin, Juho J Miettinen, et al.

Leukemia|March 24, 2019

Correction: Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphomaShamzah Araf, Jun Wang, Koorosh Korfi, et al.

Haematologica|December 24, 2025

A novel GATA1 variant linking germline and somatic myelodysplastic syndrome in two patientsNuria Revilla, Mireia Atance, Jose María Grasa, et al.

Proceedings of the National Academy of Sciences of the United States of America|July 11, 2018

Genome instability is a consequence of transcription deficiency in patients with bone marrow failure harboring biallelic <i>ERCC6L2</i> variantsHemanth Tummala, Arran D Dokal, Amanda Walne, et al.

Iscience|June 29, 2026

Pan-cancer analysis reveals Rho kinase addiction as a vulnerability of de-differentiated cancer cellsJaume Barcelo, Yumiko Teigen, Joshua Alexander James Martin, et al.

Leukemia|April 9, 2025

DEK::NUP214 acts as an XPO1-dependent transcriptional activator of essential leukemia genesFadimana Kaya, Findlay Bewicke-Copley, Juho J Miettinen, et al.

Nature Communications|December 9, 2022

The transcription factor DDIT3 is a potential driver of dyserythropoiesis in myelodysplastic syndromesNerea Berastegui, Marina Ainciburu, Juan P Romero, et al.

Leukemia|August 26, 2024

Stearoyl-CoA desaturase inhibition is toxic to acute myeloid leukemia displaying high levels of the de novo fatty acid biosynthesis and desaturationVilma Dembitz, Hannah Lawson, Richard Burt, et al.

Nature Communications|February 27, 2020

The complex genetic landscape of familial MDS and AML reveals pathogenic germline variantsAna Rio-Machin, Tom Vulliamy, Nele Hug, et al.

Blood Advances|July 5, 2023

Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41Claire C Homan, Michael W Drazer, Kai Yu, et al.

Pageof 2

Search research articles

Showing results (11-20 of 20) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 20 results.

Signal Transduction and Targeted Therapy|February 27, 2023

Leukemia|March 24, 2019

Correction: Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphomaShamzah Araf, Jun Wang, Koorosh Korfi, et al.

Haematologica|December 24, 2025

A novel GATA1 variant linking germline and somatic myelodysplastic syndrome in two patientsNuria Revilla, Mireia Atance, Jose María Grasa, et al.

Proceedings of the National Academy of Sciences of the United States of America|July 11, 2018

Genome instability is a consequence of transcription deficiency in patients with bone marrow failure harboring biallelic <i>ERCC6L2</i> variantsHemanth Tummala, Arran D Dokal, Amanda Walne, et al.

Iscience|June 29, 2026

Pan-cancer analysis reveals Rho kinase addiction as a vulnerability of de-differentiated cancer cellsJaume Barcelo, Yumiko Teigen, Joshua Alexander James Martin, et al.

Leukemia|April 9, 2025

DEK::NUP214 acts as an XPO1-dependent transcriptional activator of essential leukemia genesFadimana Kaya, Findlay Bewicke-Copley, Juho J Miettinen, et al.

Nature Communications|December 9, 2022

The transcription factor DDIT3 is a potential driver of dyserythropoiesis in myelodysplastic syndromesNerea Berastegui, Marina Ainciburu, Juan P Romero, et al.

Leukemia|August 26, 2024

Stearoyl-CoA desaturase inhibition is toxic to acute myeloid leukemia displaying high levels of the de novo fatty acid biosynthesis and desaturationVilma Dembitz, Hannah Lawson, Richard Burt, et al.

Nature Communications|February 27, 2020

The complex genetic landscape of familial MDS and AML reveals pathogenic germline variantsAna Rio-Machin, Tom Vulliamy, Nele Hug, et al.

Blood Advances|July 5, 2023

Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41Claire C Homan, Michael W Drazer, Kai Yu, et al.

Pageof 2